Company GINO BIOW Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Business Summary
Number of employees: 1,218
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Engineering
57.1
%
| 144 | 30.1 % | 144 | 57.1 % | -0.09% |
Biosecurity
42.9
%
| 334 | 69.9 % | 108 | 42.9 % | -67.69% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 478 | 100.0 % | 251 | 100.0 % | -47.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Jason Kelly
FOU | Founder | 43 | 07-12-31 |
Mark Dmytruk
DFI | Director of Finance/CFO | 52 | 21-09-15 |
Steven Coen
AUD | Comptroller/Controller/Auditor | 58 | 23-05-14 |
Karen Tepichin
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 20-12-31 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
Kathy Hannan
BRD | Director/Board Member | 62 | 22-08-01 |
Harry Sloan
BRD | Director/Board Member | 74 | 21-09-15 |
Jason Kelly
FOU | Founder | 43 | 07-12-31 |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Director/Board Member | 51 | 21-09-15 | |
Shyam Sankar
BRD | Director/Board Member | 42 | 21-09-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 120,000,000 | 0 | 0 | 67.82 % |
Stock B | 10 | 405,065,015 | 0 | 0 | |
Stock C | 1 | 1,823,890,953 | 1,593,162,360 ( 87.35 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
11,535,246 | 2.58% | 1,385,729 $ |
Company contact information
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue 8th floor
02210, Boston
+
http://www.ginkgobioworks.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+39.04% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |